Difference between revisions of "DZI20-239-Case-1"

From MGH Learn Pathology
(Created page with "{{dziCase |order_date=November 24, 2020 07:28:40 PM |user=Kx601 |dziorder=DZI20-239 |case_id=1 |publish_timestamp=11/25/2020 13:00:00 |clinical_hx=50M, enlarged aortocaval lym...")
 
(Added status template)
 
(7 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{dziCase
+
{{ServiceRequestCase
|order_date=November 24, 2020 07:28:40 PM
+
|identifier=DZI20-239-Case-1
|user=Kx601
+
|intent=order
|dziorder=DZI20-239
+
|category=409073007
|case_id=1
+
|priority=routine
|publish_timestamp=11/25/2020 13:00:00
+
|orderDetail=case
|clinical_hx=50M, enlarged aortocaval lymph node. History of RCC.
+
|locationCode=learn
|case_diagnosis=Metastatic chromophobe renal cell carcinoma
+
|basedOn=DZI20-239
 +
|code=outs
 +
|supportingInfo=Recurrent CMML2 vs AMML vs MDS EB2
 +
|reasonCode=65 yo woman with fatigue and abnormal CBC and smear.
 +
WBC 9.21; HGB 8.7 (L); HCT 24.6 (L)  PLT 49 (L)  MCV 103.4 (H)
 +
DIFF: NEUTS 19.1 (L); LYMPHS 36.5;  REACTIVE LYMPHS 7.0 (H);
 +
MONOS 28.7 (H)  (4 - 11 %); OTHER CELLS 8.7 (H)
 +
|subject=MGH
 +
|performer=VN048
 +
|authoredOn=November 24, 2020 07:28:40 PM
 +
|requester=Kx601
 +
|sequence=1
 +
|access=public
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=November 24, 2020 07:28:40 PM
+
|basedOn=DZI20-239-Case-1
|user=Kx601
+
|type=image
|source_filename=Z0FBQUFBQmZ2VjhhRDFsQUFPMllfOEZMbGY2cTJINVRJV1lqdFJ1WWpHLU9DNk0wdXFPTFVkSVdtV0pVemx5VVpTOGd2SFJSWUY5dC1rM3VaYVFPd2todXlXaWxkYzBVOVE9PQ
+
|view=show
|slide_stain=Papanicolaou
+
|partOf=DZI20-239
|slide_anatomy=Hide
+
|frames=1
 +
|identifier=DZI20-239-Case-1_1
 +
|subject=Z0FBQUFBQmZ2dHJiWTlyMmtDMFlKZmhXNnpxdjJKVzVFOGpJd1JvWURadE44MVJfOWotTFdnVWtwakp0NkRnb2pWZ203Mk9iUEtEenF4QkxSUE42TmZKbVdRdlVvYzR2Q2c9PQ
 +
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Kx601
 +
|authoredOn=November 24, 2020 07:28:40 PM
 
}}
 
}}

Latest revision as of 14:02, December 9, 2024

DZI20-239-Case-1
65 yo woman with fatigue and abnormal CBC and smear.

WBC 9.21; HGB 8.7 (L); HCT 24.6 (L)  PLT 49 (L) MCV 103.4 (H) DIFF: NEUTS 19.1 (L); LYMPHS 36.5; REACTIVE LYMPHS 7.0 (H);

MONOS 28.7 (H) (4 - 11 %); OTHER CELLS 8.7 (H)
Recurrent CMML2 vs AMML vs MDS EB2
December 2, 2020